Using real-world data to evaluate the association of incretin-based therapies with risk of acute pancreatitis: a meta-analysis of 1 324 515 patients from observational studies
出版年份 2014 全文链接
标题
Using real-world data to evaluate the association of incretin-based therapies with risk of acute pancreatitis: a meta-analysis of 1 324 515 patients from observational studies
作者
关键词
-
出版物
DIABETES OBESITY & METABOLISM
Volume 17, Issue 1, Pages 32-41
出版商
Wiley
发表日期
2014-09-08
DOI
10.1111/dom.12386
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Glucagon-like peptide-1 receptor agonists and pancreatitis: A meta-analysis of randomized clinical trials
- (2014) Matteo Monami et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Acute Pancreatitis in Patients with Type 2 Diabetes Mellitus Treated with Dipeptidyl Peptidase-4 Inhibitors: A Population-Based Nested Case-Control Study
- (2014) Hsin-Chun Chou et al. DRUG SAFETY
- Pancreatic Safety of Incretin-Based Drugs — FDA and EMA Assessment
- (2014) Amy G. Egan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies
- (2014) L. Li et al. BMJ-British Medical Journal
- Incretin based drugs and risk of acute pancreatitis in patients with type 2 diabetes: cohort study
- (2014) J.-L. Faillie et al. BMJ-British Medical Journal
- A Critical Analysis of the Clinical Use of Incretin-Based Therapies: The benefits by far outweigh the potential risks
- (2013) M. A. Nauck DIABETES CARE
- A prospective, claims-based assessment of the risk of pancreatitis and pancreatic cancer with liraglutide compared to other antidiabetic drugs
- (2013) D. Funch et al. DIABETES OBESITY & METABOLISM
- Dipeptidyl peptidase-4 inhibitors and pancreatitis risk: a meta-analysis of randomized clinical trials
- (2013) M. Monami et al. DIABETES OBESITY & METABOLISM
- American Association of Clinical Endocrinologists' Comprehensive Diabetes Management Algorithm 2013 Consensus Statement
- (2013) Alan Garber et al. Endocrine Practice
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
- (2013) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- Has pancreatic damage from glucagon suppressing diabetes drugs been underplayed?
- (2013) D. Cohen BMJ-British Medical Journal
- Comparative safety and effectiveness of sitagliptin in patients with type 2 diabetes: retrospective population based cohort study
- (2013) D. T. Eurich et al. BMJ-British Medical Journal
- Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus
- (2013) Sonal Singh et al. JAMA Internal Medicine
- Incretin therapies and risk of hospital admission for acute pancreatitis in an unselected population of European patients with type 2 diabetes: a case-control study
- (2013) Carlo B Giorda et al. Lancet Diabetes & Endocrinology
- Safety and Tolerability of Sitagliptin in Type 2 Diabetes: Pooled Analysis of 25 Clinical Studies
- (2013) Samuel S. Engel et al. Diabetes Therapy
- Liraglutide-associated acute pancreatitis
- (2012) E. Knezevich et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2012) S. E. Inzucchi et al. DIABETES CARE
- A meta-analysis of serious adverse events reported with exenatide and liraglutide: Acute pancreatitis and cancer
- (2012) Carlos Alves et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Exenatide Therapy and the Risk of Pancreatitis and Pancreatic Cancer in a Privately Insured Population
- (2012) John A. Romley et al. Diabetes Technology & Therapeutics
- Relative risk of acute pancreatitis in initiators of exenatide twice daily compared with other anti-diabetic medication: a follow-up study
- (2012) M. Wenten et al. DIABETIC MEDICINE
- A cohort study of acute pancreatitis in relation to exenatide use
- (2011) D. D. Dore et al. DIABETES OBESITY & METABOLISM
- Vildagliptin-Induced Acute Pancreatitis
- (2011) Christian Girgis et al. Endocrine Practice
- Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1–Based Therapies
- (2011) Michael Elashoff et al. GASTROENTEROLOGY
- Acute Pancreatitis in Type 2 Diabetes Treated With Exenatide or Sitagliptin: A retrospective observational pharmacy claims analysis
- (2010) R. Garg et al. DIABETES CARE
- Observational studies: going beyond the boundaries of randomized controlled trials
- (2010) Wenying Yang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide
- (2009) David D. Dore et al. CURRENT MEDICAL RESEARCH AND OPINION
- Increased Risk of Acute Pancreatitis and Biliary Disease Observed in Patients With Type 2 Diabetes: A retrospective cohort study
- (2009) R. A. Noel et al. DIABETES CARE
- Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
- (2008) D. M. Nathan et al. DIABETES CARE
- Selective Reporting of Adjusted Estimates in Observational Epidemiology Studies: Reasons and Implications for Meta-analyses
- (2008) Jaime Peters et al. EVALUATION & THE HEALTH PROFESSIONS
- Exenatide and Rare Adverse Events
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis
- (2008) Debora Williams-Herman et al. BMC Endocrine Disorders
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now